Thursday, October 20, 2016

  Hall A  
 18:15 – 19:30 Opening Session
19:30 – 20:30 Networking Reception


  Friday, October 21, 2016

  Hall A Hall B 
 08:30 – 09:30 Lecture: From triggering to targeting: New insights into the early pathogenesis of rheumatoid arthritis provide new opportunities for therapy Lecture session: Genetics and proteomics in osteoarthritis
09:30 – 10:20 Debate: Biologics vs. small molecules in the management of rheumatoid arthritis Debate: Pain in osteoarthritis: Is pain relief good or bad for patients?
 10:20 – 10:40 Coffee break and poster viewing
10:40 – 11:30 Lecture: Fatigue, the new challenge in inflammatory arthritis Lecture session: Musculoskeletal pain: From molecules to experimental models
11:30 – 12:40 Industry Symposium I
12:40 – 13:20 Lunch break and poster viewing
13:20 – 14:20 Industry Symposium II
14:20 – 15:10 Debate: Drug levels, antibody levels: Do we really need them in daily clinical practice? Debate: The origin of pain in osteoarthritis
15:10 – 16:00 Lecture: Fertility and pregnancy issues in rheumatoid arthritis Lecture session: Imaging in musculoskeletal diseases: Usefulness in establishing diagnosis and therapeutic intervention
16:00 – 16:20 Coffee break and poster viewing
16:20 – 17:20 Lecture session: New trial designs in rheumatoid arthritis Lecture session: Challenges in the management of osteoarthritis
17:20 – 17:50 Oral presentations Oral presentations
17:50 – 18:40 Lecture session: Beyond the joints: Addressing the needs of RA patients Round Table: Identifying responders to intraarticular therapy in osteoarthritis


  Saturday, October 22, 2016

  Hall A Hall B 
 08:30 – 09:20 Round Table: ACPA+ vs. ACPA-: Does it make a difference? Debate: Best approach for treating musculoskeletal pain?
09:20 – 10:20 Round Table: Biosimilars: Advantages and disadvantages Debate: MRI – Clinical: Which endpoint is most predictive of disease outcome?
 10:20 – 10:50 Coffee break and poster viewing
10:50 – 11:20 Laureate Abstracts and Award Ceremony
11:20 – 12:10 Round Table: Dose reduction in biologics: When and how? Round Table: Management of pain in osteoarthritis: Treat to which target?
12:10-13:15 Lunch break and poster viewing
13:15-14:05 Lecture: Role of the fibroblast in the perpetuation of synovitis Lecture session: Lessons learned from clinical trials: How to build the future?
14:05-14:55 Lecture: The role and importance of patient reported outcomes in the disease assessment of
rheumatoid arthritis
Lecture session: Low back pain phenotyping patients help to establish specific treatment
14:55-15:25 Coffee break and poster viewing
15:25-16:15 Debate: Glucocorticoids in rheumatoid arthritis: Is there a role in 2016? Debate: The usefulness of spinal steroid injections for sciatica and low back pain
16:15-16:30 Closing Remarks
Rheumatoid Arthritis – Inflammatory Arthritis
Osteoarthritis – Pain – Spondylarthropathies